OTCMKTS:BAXSQ - Baxano Surgical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0040 0.00 (0.00 %) (As of 09/25/2018 03:29 AM ET)Previous Close$0.0040Today's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket Capitalization$149,180.00P/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionChartEarnings HistoryInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company's other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient's hip for use in fusion procedures. Receive BAXSQ News and Ratings via Email Sign-up to receive the latest news and ratings for BAXSQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A SymbolOTCMKTS:BAXSQ CUSIPN/A Webbaxanosurgical.com Phone+1-919-8000020 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-126.01% Return on Equity-117.23% Return on Assets-56.63% Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$149,180.00 Baxano Surgical (OTCMKTS:BAXSQ) Frequently Asked Questions What is Baxano Surgical's stock symbol? Baxano Surgical trades on the OTCMKTS under the ticker symbol "BAXSQ." How were Baxano Surgical's earnings last quarter? Baxano Surgical Inc (OTCMKTS:BAXSQ) announced its earnings results on Tuesday, August, 5th. The medical device company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.14) by $0.04. The medical device company earned $4.66 million during the quarter, compared to analyst estimates of $5.33 million. Baxano Surgical had a negative net margin of 126.01% and a negative return on equity of 117.23%. View Baxano Surgical's Earnings History. How do I buy shares of Baxano Surgical? Shares of BAXSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Baxano Surgical's stock price today? One share of BAXSQ stock can currently be purchased for approximately $0.0040. How big of a company is Baxano Surgical? Baxano Surgical has a market capitalization of $149,180.00. What is Baxano Surgical's official website? The official website for Baxano Surgical is http://baxanosurgical.com. How can I contact Baxano Surgical? Baxano Surgical's mailing address is 110 Horizon Dr Ste 230, RALEIGH, NC 27615-4927, United States. The medical device company can be reached via phone at +1-919-8000020. MarketBeat Community Rating for Baxano Surgical (OTCMKTS BAXSQ)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 78 (Vote Outperform)Underperform Votes: 56 (Vote Underperform)Total Votes: 134MarketBeat's community ratings are surveys of what our community members think about Baxano Surgical and other stocks. Vote "Outperform" if you believe BAXSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAXSQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/25/2018 by MarketBeat.com StaffFeatured Article: Do stock splits help investors?